Parnell was originally established in Sydney, Australia over 50 years ago and is now a leading veterinary pharmaceutical business in 14 countries, focused on companion and dairy animals. Our vision is to discover, develop and deliver innovative therapeutic solutions to address unmet needs in the animal health market.
In addition to creating products that provide superior, integrated solutions, we also develop revolutionary interactive digital technologies that connect veterinarians to pet parents and dairy producers, establishing a partnership for animal health management. In 2012, Parnell opened a second site in Kansas City, the heart of the U.S. Animal Health Corridor, to complement our state-of-the-art pharmaceutical FDA, TGA and APVMA accredited sterile manufacturing facility in Sydney.
Parnell is a global veterinary pharmaceutical and digital technology company. We have a rich pipeline of pharmaceuticals and nutraceuticals complemented by internally developed digital technology. We serve the animal health community by providing companion animal solutions focused on mobility and also skin and coat and fertility solutions for dairy animals.
Parnell’s corporate vision is to discover, develop and deliver the best veterinary pharmaceutical solutions.